DOI QR코드

DOI QR Code

The Analysis of Registration Status of Interventional Clinical Trials for Children and Adolescents with Chronic Cough - Focused on WHO ICTRP -

소아 청소년 만성기침 환자를 대상으로 한 중재 임상시험 등록 현황 분석 - WHO ICTRP를 중심으로 -

  • Jeong Yoon Kyoung (Department of Korean Pediatric, Graduate School, Kyung Hee University ) ;
  • Choi Seo Yeon (Department of Pediatrics of Korean Medicine, Kyung Hee University College of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Bang Miran (Department of Pediatrics of Korean Medicine, Kyung Hee University College of Korean Medicine, Kyung Hee University Hospital at Gangdong) ;
  • Lee Jun-Hwan (KM Science Research Division, Korea Institute of Oriental Medicine ) ;
  • Lee Boram (KM Science Research Division, Korea Institute of Oriental Medicine ) ;
  • Chang Gyu Tae (Department of Korean Pediatric, Graduate School, Kyung Hee University )
  • 정윤경 (경희대학교 대학원 한방소아과) ;
  • 최서연 (강동경희대학교병원 한방소아과) ;
  • 방미란 (강동경희대학교병원 한방소아과) ;
  • 이준환 (한국한의학연구원 한의과학연구부) ;
  • 이보람 (한국한의학연구원 한의과학연구부) ;
  • 장규태 (경희대학교 대학원 한방소아과)
  • Received : 2023.07.25
  • Accepted : 2023.08.21
  • Published : 2023.08.31

Abstract

Objectives We aimed to analyze the registration status of interventional clinical trials in children and adolescents with chronic cough. Methods All interventional clinical trials registered up to 3 July, 2023 on the international clinical trial registry platform (ICTRP) of the World Health Organization (WHO) were analyzed. Information was extracted including study design, interventions, inclusion and exclusion criteria, and outcome indicators. Results A total of 18 interventional clinical trials were analyzed. For study design, multicentre trials, randomized allocation, parallel group design and phase 4 trials were the most frequently reported. Blinding was used in 44.4% and informed consents were obtained from 61.1%. For intervention, drugs were used in 61.1%, using placebo control group in 27.8%. Quality of life questionnaires were most frequently reported in 50% as the primary outcome, and adverse events were the most as the secondary outcome. In most cases, the assessment timepoints were after two weeks. Conclusions Based on the characteristics of clinical trial design analyzed in this study, it is necessary to design traditional Korean medicine clinical trials with improved quality and accuracy of information.

Keywords

Acknowledgement

본 연구는 보건복지부의 재원으로 한국보건산업진흥원의 보건의료기술연구개발사업 지원에 의하여 이루어진 것임 (과제고유번호: HF22C0011).

References

  1. World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013;310(20):2191-4.  https://doi.org/10.1001/jama.2013.281053
  2. Ministry of Food and Drug Safety. Good clinical practice of the international council for harmonisation (ICH GCP) [Internet]. Clinical Drafting Department; 2020 [cited 2023 Jul 17]. Available from: https://www.mfds.go.kr/brd/m_218/view.do?seq=33329. 
  3. Catherine DA, Drazen JM, Frizelle FA, Haug C, Hoey J, Horton R, Kotzin S, Laine C, Marusic A, Overbeke AJ, Schroeder TV, Sox HC, Van Der Weyden MB. Clinical trial registration: a statement from the international committee of medical journal editors. N Engl J Med. 2004;351(12):1250-1.  https://doi.org/10.1056/NEJMe048225
  4. Lee SM. Evidence-based healthcare: seeking for the broken virtuous circle. J Korean Med Assoc. 2009;52(6):534 
  5. Ahn HS, Kim HJ. An introduction to systematic review. J Korean Med Assoc. 2014;57(1):49-55.  https://doi.org/10.5124/jkma.2014.57.1.49
  6. Dickersin K, Min YI. Publication bias: the problem that won't go away. Ann N Y Acad Sci. 1993;703(1):146-8.  https://doi.org/10.1111/j.1749-6632.1993.tb26343.x
  7. Lamberink HJ, Vinkers CH, Lancee M, Damen JAA, Bouter LM, Otte WM, Tijdink JK. Clinical trial registration patterns and changes in primary outcomes of randomized clinical trials from 2002 to 2017. JAMA Intern Med. 2022;182(7):779-82.  https://doi.org/10.1001/jamainternmed.2022.1551
  8. World Health Organization. International clinical trials registry platform (ICTRP) | primary registries [Internet]. WHO: World Health Organization; 2023 [cited 2023 Jul 17]. Available from: https://www.who.int/clinicaltrials-registry-platform/network/partner-registries. 
  9. Park HY. Primary registry of the WHO international clinical trial registry platform: clinical research information service (CRIS). J Korean Med Assoc. 2011;54(1):92. 
  10. Koo EJ, Kweon JH, Kim KB, Kim BNR, Kim JH, Min SY, Park EJ, Baek JH, Sung HK, Yu SA, Lee SH, Lee JH, Lee JY, Lee HL, Chang GT, Jung MJ, Jung AR, Jung HS, Cheon JH. Pediatrics of Korean medicine. 3rd ed. Seoul: Ui Sung Dang Publishing Co. 2020:966-7. 
  11. Choi SH, Song DJ, Yum HY, Park YM, Rha YH. Chronic cough in children. Allergy Asthma Respir Dis. 2016;4(4):235-47.  https://doi.org/10.4168/aard.2016.4.4.235
  12. Lee ES, Bang JS, Oh YJ, Lee JW, Sung TJ, Lee YJ, Lee KH. Risk factors of allergic sensitization in preschool children with chronic cough. Allergy Asthma Respir Dis. 2015;3(2):105. 
  13. Seo HS, Kim HY, Kim JR, Kim SM, Lee SH, Lee JY. A retrospective chart review of the use of Korean medicine in children with chronic cough. J Pediatr Korean Med. 2022;36(4):2. 
  14. Lee SY. The clinical study in children with cough. J Pediatr Korean Med. 1999;13(14):1-8. 
  15. Yasui K, Nagaoka Y, Ogawa K, Itamura S, Yashiro M, Ochi H. Recurrent chronic cough, wheeze and their control without corticosteroids in 1 to 5 year-old children. Int J Pediatr Neonat Care. 2016;2:1-5.  https://doi.org/10.15344/2455-2364/2016/113
  16. Mincheva RK, Kralimarkova TZ, Rasheva M, Dimitrov Z, Nedeva D, Staevska M, Papochieva V, Perenovska P, Bacheva K, Dimitrov VD, Popov TA. A real - life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic cough. Cough. 2014;10(1):2. 
  17. Bucca C, Culla B, Brussino L, Ricciardolo FL, Cicolin A, Heffler E, Bugiani M, Rolla G. Effect of iron supplementation in women with chronic cough and iron deficiency. Int J Clin Pract. 2012;66(11):1095-100.  https://doi.org/10.1111/ijcp.12001
  18. Chamberlain MS, Garrod R, Clark L, Douiri A, Parker SM, Ellis J, Fowler SJ, Ludlow S, Hull JH, Chung KF, Lee KK, Bellas H, Pandyan A, Birring SS. Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial. Thorax. 2017;72(2):129-36.  https://doi.org/10.1136/thoraxjnl-2016-208843
  19. Chaudhury A, Parija SC. Lophomonas blattarum: A new flagellate causing respiratory tract infections. Trop Parasitol. 2020;10(1):7-11. 
  20. Korean National Institute for Bioethics Policy. Basic textbooks for those involved in clinical trials [internet]. Korea Food and Drug Administration; 2006 [cited 2023 Jul 19]. Available from: https://www.nibp.kr/xe/info4_5/1495. 
  21. Anhaee Nasseri Z, Mirsadraee M, Manafi Varkiani M, Ghaderi Y, Berenji F, Ghaffari S. Effective treatment of chronic cough with tinidazole as the newest anti-protozoa against lophomonas blattarum. J Parasitol Res. 2022;1-5. 
  22. Ruffles TJC, Goyal V, Marchant JM, Masters IB, Yerkovich S, Buntain H, Cook A, Schultz A, Upham JW, Champion A, Versteegh L, Chang AB. Duration of amoxicillin-clavulanate for protracted bacterial bronchitis in children (DACS): a multi-centre, double blind, randomised controlled trial. Lancet Respir Med. 2021;9(10):1121-9.  https://doi.org/10.1016/S2213-2600(21)00104-1
  23. O'Grady KF, Grimwood K, Torzillo PJ, Rablin S, Lovie-Toon Y, Kaus M, Arnold D, Roberts J, Buntain H, Adsett D, King A, Scott M, Anderson J, Toombs M, Chang AB. Effectiveness of a chronic cough management algorithm at the transitional stage from acute to chronic cough in children: a multicenter, nested, single-blind, randomised controlled trial. Lancet Child Adolesc Health. 2019;3(12):889-98.  https://doi.org/10.1016/S2352-4642(19)30327-X
  24. Chang AB, Robertson CF, Van Asperen PP, Glasgow NJ, Mellis CM, Masters IB, Teoh L, Tjhung I, Morris PS, Petsky HL, Willis C, Landau LI. A multicenter study on chronic cough in children: burden and etiologies based on a standardized management pathway. Chest. 2012;142(4):943-50.  https://doi.org/10.1378/chest.11-2725
  25. Marchant J, Masters IB, Champion A, Petsky H, Chang AB. Randomised controlled trial of amoxycillin clavulanate in children with chronic wet cough. Thorax. 2012;67(8):689-93.  https://doi.org/10.1136/thoraxjnl-2011-201506
  26. Tomar R, Yadav B, Singh H, Hetalben A, Khanduri S, Sharma BS, Rana R, Singhal R, Chandrasekhararao B, Sirkanth N, Dhiman KS. A clinical study to evaluate the efficacy of Ayurvedic intervention in management of chronic bronchitis. J Res Ayurvedic Sci. 2022;6(3):101-8.  https://doi.org/10.4103/jras.jras_3_22
  27. Chang AB, Oppenheimer JJ, Kahrilas PJ, Kantar A, Rubin BK, Weinberger M, Irwin RS. Chronic cough and gastroesophageal reflux in children: CHEST guideline and expert panel report. Chest. 2019;156(1):131-40. 
  28. National Institue of Food and Drug Safety Evaluation. Guidelines for clinical trial evaluation in children [Internet]. Cheongju: Ministry of Food and Drug Safety; 2018 [updated 2018 Nov 30; cited 2023 Jul 18]. Available from: https://www.mfds.go.kr/brd/m_1060/view.do?seq=14302&srchFr=&srchTo=&srchWord=%EC%95%BD%EB%AC%BC%EC%9D%B4%EC%83%81%EB%B0%98%EC%9D%91+%EB%B0%8F+%EC%9D%B4%EC%83%81%EC%82%AC%EB%A1%80+%EC%A0%84%EC%9E%90%EB%B3%B4%EA%B3%A0+%EA%B0%80%EC%9D%B4%EB%93%9C%EB%9D%BC%EC%9D%B8&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&Data_stts_gubun=C9999&page=1. 
  29. Shim SB, Seo HS, Hee LH, Lim LH. The Current state of registration of interventional clinical trials for children and adolescents with precocious puberty. J Pediatr Korean Med. 2022;36(3):1-18. 
  30. Koh HJ, Min DG, Baek SH, Ahn SY, Joo AY, Jong YH, Lee YH, Lim DS, Jeon YG, Jeon J, Jung HG, Cho HY, Choi IY. Guidelines for clinical trials, basic guide for understanding and executing clinical trials. Cheongju: Korea Health Industry Development Institute. 2018:30. 
  31. Ministry of Food and Drug Safety. Guidelines for establishing control groups for pharmaceutical clinical trials [Internet]. Cheongju: Food and Drug Safety Evaluation Institute, Drug Review Division Oncology Drug Division; 2018 [cited 2023 Jul 22]. Available from: https://www.mfds.go.kr/brd/m_218/view.do?seq=33336&srchFr=&srchTo=&srchWord=srchTp&srchTp=&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=4 
  32. Ministry of Food and Drug Safety. International ethical standards for clinical trials recommended by WHO [Internet]. Seoul: National Institute of Toxicology Clinical Pharmacology Team; 2005 [cited 2023 Jul 18]. Available from: https://www.mfds.go.kr/brd/m_218/view.do?seq=742&srchFr=&srchTo=&srchWord=%EC%8B%AC%EC%82%AC&srchTp=0&itm_seq_1=0&itm_seq_2=0&multi_itm_seq=0&company_cd=&company_nm=&page=7. 
  33. Choi EK, Park HY. Review of worldwide regulatory and institutional requirements regarding clinical trial registration. Public Health Wkly Rep. 2015;8(30):691. 
  34. Kim SH, Yoon HJ. Exhaled nitric oxide measurement for asthma management. Korean J Med. 2017;92(5):453-7. https://doi.org/10.3904/kjm.2017.92.5.453